Synapse

← ONCOLOGY

Papers in ONCOLOGY

Page 2 · newest first

  1. Current Treatments in Mantle Cell LymphomaONCOLOGY · 2023
  2. Biomarkers for Response to Anti–PD-1/Anti–PD-L1 Immune Checkpoint Inhibitors: A Large Meta-AnalysisONCOLOGY · 2023
  3. The Complexities and Art of Interpreting Biomarkers and Response to Immune Checkpoint InhibitorsONCOLOGY · 2023
  4. An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case ReportONCOLOGY · 2023
  5. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma温州职业技术学院学报 · 2023
  6. The Management of Relapsed and Refractory Multiple MyelomaONCOLOGY · 2023
  7. Cutaneous T-Cell Lymphoma: Current and Emerging TherapiesONCOLOGY · 2023
  8. Survival of Patients With Inoperable Non–Small Cell Lung Cancer With Baseline Severe Pulmonary Dysfunction: Impacts of Thoracic Radiotherapy and Predictive Analysis for Acute Radiation PneumonitisONCOLOGY · 2023
  9. How to Treat Metastatic Malignant Triton Tumor in an AdolescentONCOLOGY · 2022
  10. Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-USONCOLOGY · 2022
  11. Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research RecommendationsONCOLOGY · 2022
  12. Deciding Which Cancer-Related Fatigue Assessment Tool to Use Just Got Much EasierONCOLOGY · 2022
  13. Current Treatment of Peripheral T-cell LymphomaONCOLOGY · 2022
  14. Making Progress in PTCL: Significant Unmet NeedsONCOLOGY · 2022
  15. Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell CarcinomaONCOLOGY · 2022
  16. Current Treatments in Marginal Zone LymphomaONCOLOGY · 2022
  17. Metastatic Renal Cell Carcinoma With Sarcomatoid FeaturesONCOLOGY · 2022
  18. Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIsONCOLOGY · 2022
  19. The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical StudyONCOLOGY · 2022
  20. The Effect of Prior Cancer on Survival of Patients With ThymomaONCOLOGY · 2022
  21. Cancer Pain and Opioid Use DisorderONCOLOGY · 2022
  22. Predictors of Poor Adherence to Follow-up Care in Survivors of Childhood CancerONCOLOGY · 2022
  23. Female Representation in Clinical Practice Guideline Panels in 2 Major Cancer OrganizationsONCOLOGY · 2022
  24. Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017ONCOLOGY · 2022
  25. Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder CancerONCOLOGY · 2022
  26. Future Directions in the Management of Non–Small Cell Lung Cancer Harboring Driver MutationsONCOLOGY · 2022
  27. Relapsed or Refractory Diffuse Large B-Cell Lymphoma: “Dazed and Confused”ONCOLOGY · 2022
  28. Management of Testicular Germ Cell Tumor With Somatic-Type MalignancyONCOLOGY · 2022
  29. Current Treatment of Burkitt Lymphoma and High-Grade B-Cell LymphomasONCOLOGY · 2022
  30. Current Frontline Treatment of Multiple MyelomaONCOLOGY · 2022
  31. Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and TherapyONCOLOGY · 2022
  32. Follicular Lymphoma: a Focus on Current and Emerging TherapiesONCOLOGY · 2022
  33. Current Frontline Treatment of Diffuse Large B-Cell LymphomaONCOLOGY · 2022
  34. Characterization of Blood-Based Molecular Profiling in Pancreatic AdenocarcinomaONCOLOGY · 2021
  35. Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous RituximabONCOLOGY · 2021
  36. A New Horizon in Cancer Care: Liquid BiopsyONCOLOGY · 2021
  37. Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous CarcinosarcomaONCOLOGY · 2021
  38. The complexity of carcinosarcomaONCOLOGY · 2021
  39. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell TumorONCOLOGY · 2021
  40. Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled TrialsONCOLOGY · 2021
  41. An Evolving Relationship Between Medical Oncologists and Genetic Counselors in Prostate CancerONCOLOGY · 2021
  42. COLOMATE challenge to overcome resistance in metastatic colorectal cancerONCOLOGY · 2021
  43. Germline Testing in Prostate Cancer: When and Who to TestONCOLOGY · 2021
  44. Clinically Meaningful Outcome Measures: A Role for Geriatric AssessmentONCOLOGY · 2021
  45. Opsoclonus-Myoclonus–Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?ONCOLOGY · 2021
  46. Value of Geriatric Assessment in Patients With Genitourinary CarcinomaONCOLOGY · 2021
  47. Addressing Resistance to Targeted Therapies in Metastatic Colorectal CancerONCOLOGY · 2021
  48. The Role of Autologous Stem Cell Transplantation in AmyloidosisONCOLOGY · 2021
  49. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant ChemotherapyONCOLOGY · 2021
  50. A 65-Year-Old Man With Back Pain and Imaging Findings of Spinal Cord CompressionONCOLOGY · 2021